Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
about
Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell deathStaphylococcus aureus - induced tumor necrosis factor - related apoptosis - inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblastsApoptosis of uninfected cells induced by HIV envelope glycoproteinsFollowing a TRAIL: update on a ligand and its five receptorsQuantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracyBeneficial effect of TRAIL on HIV burden, without detectable immune consequences.HIV induces TRAIL sensitivity in hepatocytesGenetic characterization of HIV type 1 Nef-induced vesicle secretionPotent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2lSoluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection.Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels.Mechanisms of HIV-associated lymphocyte apoptosis: 2010Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection.In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism.Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus.The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious DiseasesTracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.Isolation of a TRAIL antagonist from the serum of HIV-infected patients.Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosisHuman immunodeficiency virus type 1 protease cleaves procaspase 8 in vivoHuman and simian immunodeficiency virus-mediated upregulation of the apoptotic factor TRAIL occurs in antigen-presenting cells from AIDS-susceptible but not from AIDS-resistant species.HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK CellsExotic emerging viral diseases: progress and challenges.Depletion of B220(+)NK1.1(+) cells enhances the rejection of established melanoma by tumor-specific CD4(+) T cells.HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alphaDevelopment of treatment strategies to combat Ebola and Marburg viruses.Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion.HIV-1 immunopathogenesis: how good interferon turns bad.Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells.Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models.The tug-of-war between dendritic cells and human chronic viruses.Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.
P2860
Q24674186-306C283F-AF88-4A62-9E5D-D84839F0EAA0Q24794331-C8894500-7BF6-4838-A857-B8EE7F8AFB17Q24801374-76B1A3C5-FC12-4E8D-8646-8CC4BE7C3DC0Q28292767-DBB21631-0175-4B41-B85E-3FC137B43552Q30477329-161EC3DC-D3FC-4EB4-B0D5-C9E1AC965C16Q33366417-2728EF2C-8D94-4079-9CAD-3A7445C3D9BDQ33413051-D35AC974-369B-4D00-B8E5-A58DB72713A7Q33714550-75223E3B-BA88-4FF8-82DA-02902F4EEEDAQ33781391-2845D985-69EC-49B3-AF86-115EA5B81E66Q33849293-553405A8-9E9A-48CB-A0D1-FE602BBEC863Q33910907-9D57916D-193C-41D8-90A6-B70CB31B05BDQ34014711-DF800C52-7054-4731-A99A-03A177BB7822Q34355580-12F3C009-55C7-48F4-AB11-8386CDCB09A0Q34545417-9F0BA5F6-D9C3-4536-9000-8E4671BD471EQ34557110-305114E7-E651-4538-BF49-853151C94C75Q34664366-3A0A302B-D332-428D-B543-A7E9FB80AA09Q34808530-4E856A0B-652B-486C-94D2-1A9C4DF9C0F8Q34977020-9712A511-7B07-4B40-BA59-2F43BF611A67Q35018048-4BA90837-3E2C-48E8-9FA6-221F7E248680Q35020357-38E60D0B-9976-4D35-ABD0-0ED706DE666DQ35139607-8A67DF22-6807-4477-8D1E-6E1EB494C793Q35172090-35A2BC65-91AF-47CA-AB74-6F2DFDFA733CQ35209364-67031A9C-E657-4273-8941-16DCFADF3FCBQ35372514-DE51FC0C-F501-4A37-A20B-324F9F6D7884Q35666063-90BB81B2-AFE1-4FE3-A8AE-A29F80AF16EBQ35847699-74B966D8-4C35-4B87-85D9-567EEEFD8AD3Q35914355-C4864819-60D3-4FBE-BFBC-0432D8869CFAQ35914497-5D91E06C-6EE9-4656-B293-C9DEFDDF3515Q35922101-6031CC99-E268-432B-AA6F-E62614A60241Q35971398-DE1408D0-EF88-491A-B480-53AC0C2D4021Q36060315-7C445115-E9A9-4B5D-B70A-CB32EC3D0EA0Q36141492-7CECCAE5-58FC-42A1-BE01-BF2CD481CE1BQ36379341-8C1F1DB3-72A1-4983-A904-F13EE07BD94FQ36547702-0FB1FF3A-26B6-48F8-BE15-C670DCEB7A84Q36656715-590D35CE-B5BD-4253-9066-E923398FDEDEQ36926597-5969CFE1-493E-4A7B-B0EE-4EF142A875A6Q37150920-EDE4BBD8-69B1-45A0-AB3D-781E3B7EC29BQ37900419-AA5B88CA-8158-4914-945E-58E1BF33B655Q37952807-271EA55C-F1AA-4040-8644-7703D9913CADQ41338220-7BE74AC6-2B0F-4769-A379-B7EE0CAB0197
P2860
Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Critical contribution of tumor ...... infected hu-PBL-NOD-SCID mice.
@en
Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand
@nl
type
label
Critical contribution of tumor ...... infected hu-PBL-NOD-SCID mice.
@en
Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand
@nl
prefLabel
Critical contribution of tumor ...... infected hu-PBL-NOD-SCID mice.
@en
Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand
@nl
P2093
P2860
P356
P1476
Critical contribution of tumor ...... infected hu-PBL-NOD-SCID mice.
@en
P2093
Kayagaki N
Koyanagi Y
Mizusawa H
P2860
P304
P356
10.1084/JEM.193.5.651
P407
P577
2001-03-01T00:00:00Z